salsoline has been researched along with Parkinsonian Disorders in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maruyama, W; Naoi, M | 1 |
Ai, S; Gu, J; Jin, L; Wang, J; Xie, Y; Yamamoto, K; Zhang, W | 1 |
Boulton, AA; Davis, BA; Dostert, P; Maruyama, W; Naoi, M | 1 |
3 other study(ies) available for salsoline and Parkinsonian Disorders
Article | Year |
---|---|
Cell death in Parkinson's disease.
Topics: Animals; Apoptosis; Brain; Cell Count; Disease Models, Animal; Humans; Isoquinolines; Male; Mitochondria; Neurons; Neurotoxins; Oxidative Stress; Parkinsonian Disorders; Rats; Rats, Wistar; Salsoline Alkaloids; Signal Transduction; Tetrahydroisoquinolines; Tumor Cells, Cultured | 2002 |
Liquid chromatography with amperometric detection at a nano crystalline Ce-doped lead dioxide film modified electrode for determination of (R)-Salsolinol, (R)-N-methylsalsolinol and monoamine neurotransmitters in Parkinsonian patients' cerebrospinal fluid
Topics: Chromatography, Liquid; Electrochemistry; Electrodes; Humans; Isoquinolines; Nanotechnology; Neurotransmitter Agents; Parkinsonian Disorders; Salsoline Alkaloids; Tetrahydroisoquinolines | 2004 |
Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine.
Topics: Alkynes; Apoptosis; Dopamine; Drug Interactions; Fluorescent Dyes; Humans; Membrane Potentials; Mitochondria; Monoamine Oxidase Inhibitors; Neuroblastoma; Neurons; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Salsoline Alkaloids; Signal Transduction; Stereoisomerism; Substantia Nigra; Tetrahydroisoquinolines; Tumor Cells, Cultured | 2001 |